UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 209 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,832
-100.0%
59,839
-73.3%
0.70%
-96.8%
Q2 2021$28,881,000
+60.8%
224,391
+0.0%
22.15%
+110.2%
Q1 2021$17,960,000224,39010.54%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
HSG Holding Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
Alphabet Inc. 321,604$10,268,8150.55%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.55%
View complete list of BEAM THERAPEUTICS INC shareholders